InventisBio Statistics

Total Valuation

InventisBio has a market cap or net worth of CNY 18.37 billion. The enterprise value is 16.76 billion.

Market Cap	18.37B
Enterprise Value	16.76B

Important Dates

The next estimated earnings date is Wednesday, August 27, 2025.

Earnings Date	Aug 27, 2025
Ex-Dividend Date	n/a

Share Statistics

InventisBio has 578.33 million shares outstanding. The number of shares has decreased by -0.78% in one year.

Current Share Class	578.33M
Shares Outstanding	578.33M
Shares Change (YoY)	-0.78%
Shares Change (QoQ)	-0.46%
Owned by Insiders (%)	12.27%
Owned by Institutions (%)	26.60%
Float	364.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	109.09
PB Ratio	10.38
P/TBV Ratio	10.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-78.12
EV / Sales	99.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-74.93

Financial Position

The company has a current ratio of 22.59, with a Debt / Equity ratio of 0.01.

Current Ratio	22.59
Quick Ratio	22.44
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	-303.51

Financial Efficiency

Return on equity (ROE) is -11.58% and return on invested capital (ROIC) is -8.50%.

Return on Equity (ROE)	-11.58%
Return on Assets (ROA)	-8.04%
Return on Invested Capital (ROIC)	-8.50%
Return on Capital Employed (ROCE)	-14.18%
Revenue Per Employee	910,126
Profits Per Employee	-1.16M
Employee Count	185
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +170.95% in the last 52 weeks. The beta is 0.29, so InventisBio's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	+170.95%
50-Day Moving Average	21.11
200-Day Moving Average	13.76
Relative Strength Index (RSI)	80.35
Average Volume (20 Days)	10,877,681

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InventisBio had revenue of CNY 168.37 million and -214.53 million in losses. Loss per share was -0.38.

Revenue	168.37M
Gross Profit	167.34M
Operating Income	-254.15M
Pretax Income	-214.53M
Net Income	-214.53M
EBITDA	-248.65M
EBIT	-254.15M
Loss Per Share	-0.38

Full Income Statement

Balance Sheet

The company has 1.63 billion in cash and 22.87 million in debt, giving a net cash position of 1.61 billion or 2.78 per share.

Cash & Cash Equivalents	1.63B
Total Debt	22.87M
Net Cash	1.61B
Net Cash Per Share	2.78
Equity (Book Value)	1.77B
Book Value Per Share	3.06
Working Capital	1.74B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -214.28 million and capital expenditures -9.38 million, giving a free cash flow of -223.66 million.

Operating Cash Flow	-214.28M
Capital Expenditures	-9.38M
Free Cash Flow	-223.66M
FCF Per Share	-0.39

Full Cash Flow Statement

Margins

Gross margin is 99.39%, with operating and profit margins of -150.94% and -127.41%.

Gross Margin	99.39%
Operating Margin	-150.94%
Pretax Margin	-127.41%
Profit Margin	-127.41%
EBITDA Margin	-147.68%
EBIT Margin	-150.94%
FCF Margin	n/a

Dividends & Yields

InventisBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.78%
Shareholder Yield	n/a
Earnings Yield	-1.17%
FCF Yield	-1.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

InventisBio has an Altman Z-Score of 34.36.

Altman Z-Score	34.36
Piotroski F-Score	n/a